A recent study from Queen's University Belfast has raised concerns about the use of antidepressants and anti-anxiety medications in individuals with dementia. The research, led by Dr. Catherine Sinnamon, highlights a potential increased risk of death associated with these medications, particularly in older adults. This finding is particularly relevant given the rising prevalence of dementia, which affects over 55 million people worldwide annually.
The study, published in the Mirror, examined the prescribing trends of antidepressants and anti-anxiety medications in a Northern Ireland cohort of 28,781 people with dementia over a nine-year period. The results revealed that antidepressants were prescribed to 59.2% of individuals who died during this period, while anti-anxiety medications were prescribed to 44.8% of those who passed away. These findings suggest a slight increased risk of death associated with antidepressants and a strong increased risk with anti-anxiety medications.
Dr. Sinnamon emphasizes the importance of judicious prescribing for individuals with dementia, as they often have multiple medical conditions and are prescribed multiple medications. She states, "Sometimes these medicines may not always be appropriate. Our study aimed to uncover how antidepressant medications affect people with dementia to ensure we can provide them with the best treatment and care."
The study's principal investigator, Dr. Heather Barry, further underscores the need for regular medication reviews in individuals with dementia. She notes, "It further underscores the importance of medications being regularly and thoroughly reviewed in people with dementia, whether that be by a GP or a pharmacist, to ensure they are still appropriate and are still needed."
This research highlights a critical issue in the treatment of dementia, emphasizing the need for personalized and cautious prescribing practices. As the global population ages, the prevalence of dementia is expected to rise, making it crucial to address the potential risks associated with these medications. The findings of this study should prompt further investigation and discussion among healthcare professionals to ensure the best possible care for individuals with dementia.
